Neurocrine Bio. (NBIX) PT Raised to $142 at Oppenheimer Due to Projected Success of Crinecerfort
Tweet Send to a Friend
Oppenheimer analyst Jay Olson raised the price target on Neurocrine Bio. (NASDAQ: NBIX) to $142.00 (from $130.00) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
